Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1956 2
1958 1
1959 2
1961 1
1963 5
1964 4
1965 3
1966 3
1967 6
1968 2
1969 5
1970 2
1971 1
1973 2
1974 2
1975 2
1976 1
1977 1
1982 8
1983 9
1984 8
1985 10
1986 13
1987 11
1988 5
1989 14
1990 17
1991 13
1992 10
1993 11
1994 17
1995 10
1996 17
1997 18
1998 11
1999 21
2000 31
2001 27
2002 25
2003 39
2004 26
2005 36
2006 39
2007 43
2008 47
2009 57
2010 45
2011 43
2012 47
2013 58
2014 53
2015 47
2016 67
2017 61
2018 64
2019 72
2020 85
2021 83
2022 99
2023 69
2024 69

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,440 results

Results by year

Filters applied: . Clear all
Page 1
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Abramson JS, Solomon SR, Arnason J, Johnston PB, Glass B, Bachanova V, Ibrahimi S, Mielke S, Mutsaers P, Hernandez-Ilizaliturri F, Izutsu K, Morschhauser F, Lunning M, Crotta A, Montheard S, Previtali A, Ogasawara K, Kamdar M. Abramson JS, et al. Among authors: ogasawara k. Blood. 2023 Apr 6;141(14):1675-1684. doi: 10.1182/blood.2022018730. Blood. 2023. PMID: 36542826 Free PMC article. Clinical Trial.
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Kamdar M, Solomon SR, Arnason J, Johnston PB, Glass B, Bachanova V, Ibrahimi S, Mielke S, Mutsaers P, Hernandez-Ilizaliturri F, Izutsu K, Morschhauser F, Lunning M, Maloney DG, Crotta A, Montheard S, Previtali A, Stepan L, Ogasawara K, Mack T, Abramson JS; TRANSFORM Investigators. Kamdar M, et al. Among authors: ogasawara k. Lancet. 2022 Jun 18;399(10343):2294-2308. doi: 10.1016/S0140-6736(22)00662-6. Lancet. 2022. PMID: 35717989 Clinical Trial.
A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening.
Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, Van Marter J. Hillier TA, et al. Among authors: ogasawara kk. N Engl J Med. 2021 Mar 11;384(10):895-904. doi: 10.1056/NEJMoa2026028. N Engl J Med. 2021. PMID: 33704936 Free PMC article. Clinical Trial.
Japan Stroke Society Guideline 2021 for the Treatment of Stroke.
Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W; Committee for Stroke Guideline 2021, the Japan Stroke Society. Miyamoto S, et al. Among authors: ogasawara k. Int J Stroke. 2022 Oct;17(9):1039-1049. doi: 10.1177/17474930221090347. Epub 2022 Apr 20. Int J Stroke. 2022. PMID: 35443847 Free PMC article.
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR-T and TCR-T Cell Therapies: An Industry Perspective.
Mody H, Ogasawara K, Zhu X, Miles D, Shastri PN, Gokemeijer J, Liao MZ, Kasichayanula S, Yang TY, Chemuturi N, Gupta S, Jawa V, Upreti VV. Mody H, et al. Among authors: ogasawara k. Clin Pharmacol Ther. 2023 Sep;114(3):530-557. doi: 10.1002/cpt.2986. Epub 2023 Jul 26. Clin Pharmacol Ther. 2023. PMID: 37393588 Review.
[Preface].
Ogasawara K. Ogasawara K. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(10):1235. doi: 10.6009/jjrt.2018_JSRT_74.10.1235. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018. PMID: 30344223 Free article. Japanese. No abstract available.
Current viewpoints on DSM-5 in Japan.
Kuroki T, Ishitobi M, Kamio Y, Sugihara G, Murai T, Motomura K, Ogasawara K, Kimura H, Aleksic B, Ozaki N, Nakao T, Yamada K, Yoshiuchi K, Kiriike N, Ishikawa T, Kubo C, Matsunaga C, Miyata H, Asada T, Kanba S. Kuroki T, et al. Among authors: ogasawara k. Psychiatry Clin Neurosci. 2016 Sep;70(9):371-93. doi: 10.1111/pcn.12421. Epub 2016 Aug 31. Psychiatry Clin Neurosci. 2016. PMID: 27414748 Free article. Review.
1,440 results